This month’s Government Relations Update video delves into crucial legislative developments impacting California’s manufacturing sector.  

California legislation’s fiscal deadline is April 26th. All bills with a fiscal impact are due for consideration by the Appropriations Committees, signaling a critical phase for proposed policies.

Assemblymember Luiz Rivas’s AB 2400 takes center stage, proposing an extension of the California Alternative Energy and Advanced Transportation Financing Authority Act (CAEATFA). This act, fostering partnerships to offer financing solutions, aims to slash greenhouse gas emissions and energize economic growth. Since the act’s establishment in 2010, the sales and use tax exclusion incentive program within CAEATFA for manufacturers of green technologies identifies a nexus between California’s economic and environmental goals. Since its inception, over 128,000 jobs have been created or retained, spurring investment that totals over $2.5 billion in fiscal benefits and $415 million in environmental benefits. AB 2400, a CMTA maker bill, stands to profoundly benefit California’s manufacturers.  

Assemblymember Diane Papan’s AB 2515 raises pivotal concerns for menstrual product manufacturers in California. The bill seeks to prohibit the sale of products containing any detectable PFAS, potentially exposing manufacturers to extensive liabilities and punitive penalties. While CMTA’s members are not intentionally adding PFAS chemicals to these products, the bill contains a private right of action and the ability to levy punitive financial penalties on manufacturers. Companies should not intentionally add these chemicals, but the legislation needs additional considerations before CMTA removes its opposition.   

Stay informed with the latest updates from the Government Relations Update video series, offering invaluable insights for manufacturers navigating California’s legislative environment. 

Do you want to get exclusive government relations insights from CMTA?

📲 Reach out to members@cmta.net.